Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It will, since coming closer to financials.
Would. If they mentioned who bought them
I agree wow. That was a deep plunge.
The pull back, hmm, it'll depend on if there is pr. That will get it above $1.00 and hopefully keep it there till financials.
It's possible to break .90-95 this week should this trend continue.
That's a nice read. As it states, if there is good reason for the move in the financials, then upward we go
Insiders increased their shares this week
That is what I think as well
I believe we Will see positive news out next week. That will get us into .90-.95 range. And the financials will send us over $1
We would need news and Dtc chill off.
Easy. With financials coming soon
Why is it up?
I think we are in for news today -Tuesday.
I hope so!
Hmmm. Possible run?
Happy 4th hyelnat! I also see upside. Mid July I am expecting the share price to be .80-.85. As we get closer to Q2 financials being released
I agree, we might see it get up to .80-.85 the next couple weeks.
Hmm. I don't think there was anything to why it went up.
I see it was filed 06-01-2012 and $15k is going to go somewhere. He states not a merger or acquisition. Hmm?
Nice find.
http://www.clinicaltrials.gov/ct2/show/NCT01627106?term=mk-6621&rank=4
Did anyone else see this?
Is the word not out? It looks like a good one but there isn't buying pressure.
All if this good news, how come not really any buying pressure?
Me too. Might have to cautiously add more
I think it was indicated as a buy and not sell.
Do you know of similar stocks that had this volume bid then Put out news?(time frame)
Investors may be waiting for financials to be sure. What was the $400k buy?
Merck’s discontinuation of the oral formulation of vernakalant will not affect its support for the IV formulation. The IV formulation is approved in the EU and Latin America under the trade name Brinavess. However, Brinavess’ development path in the US has not been smooth with the US Food and Drug Administration (FDA) placing a clinical hold on the development program for the IV formulation. A phase III study, ACT V, which was suspended in 2010, was terminated later. Merck and the FDA will analyze the terminated study - results should be out in the second quarter of 2012.
Was there ever a R/s that this company implemented?
We probably won't see financials for another month. But, they have been pretty good on getting pr out. Financials will be good.
Good extended hours but again!
What's the news?
Revenues have increased 1/3
Yes and only buy and holds. I just revisited standard and poors report on qtww. It states that revenue for qtww as of April 30th has almost increased 1/3. That's not including the new purchases of hydrogen tanks.
I won't be surprised if there is news before the end of the week also.
Etrade
This is a good long haul stock. I see it only getting better. Up 80% from low. In 5 days 12% gain at close and in the past month around 67% gains.
Hmm. I am also very interested. Assuming it was well received and had no problems. I don't see why all American car companies wouldn't want in. The army is already on board!
Update part 2. Thomas Reuters updated 'fundamental' score of qtww from 2 to 8. More bullish than market of auto parts which average rating is 5.4.